News provided by Ro Dec 10, 2025, 09:00 ET Peer-reviewed study demonstrates patients treated with semaglutide through Ro achieve an average body weight loss of 16.6% over 68 weeks First study to evaluate both the long-term weight loss and safety outcomes of treatment with semaglutide via telehealth NEW YORK, Dec
This structure reflects the general pattern seen across this kind of titration schedule used in clinical settings, though a provider may pause an increase or extend a stage if a patient experiences nausea, stomach upset, or other digestive symptoms
Find a doctor Whether youre looking for a primary care physician or need to see a specialist, were here to help with experienced, compassionate care near you
Mas-FontSRos-MartinezJPrez-CalvoCVilla-DazPAldunate-CalvoSMoreno-ClariEet al
Our program in Orlando is perfect for those with a BMI of 30 or above, or those with a BMI of 27 accompanied by health complications